Amplifon, IT0004056880

Amplifon stock edges lower amid selective Italy rally and robust H1 2026 growth

Published on 09/19/2026 at 19:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Amplifon stock slipped around 0.8 percent in Milan trading as of September 19, 2026, while the group reported double digit revenue growth for H1 2026. The hearing care specialist also lifted its adjusted EBITDA and confirmed its expansion strategy for 2026.

Modernes Hörzentrum mit Beratungsraum und Hörgeräte-Ausstellung, fotorealistisch
Fotorealistisches Bild zeigt modernen Hörzentrum-Ladenraum, passend zu Amplifon S.p.A. mit ISIN IT0004056880, Sektor Medizintechnik, Illustration mit AI erstellt.

Amplifon stock (ISIN IT0004056880) was down about 0.8 percent on the Italian market as of September 19, 2026, even as the company reported solid double digit growth in its most recent half year 2026 results.

Stock moves lower in selective Italy rally

As Adalytica reported on September 19, 2026, the Italian equity market saw gains driven by a Moncler upgrade, while Amplifon and construction group Buzzi each fell about 0.78 percent, highlighting that the rally was selective rather than broad based.

Based on recent Borsa Italiana data for the primary listing in Milan, Amplifon stock traded around EUR 11.35 on September 19, 2026, with the quote embedded in a 52 week range that keeps the price clearly above its lows but below recent highs, and a market capitalization in the billions of euros as of the same trading day.

H1 2026 figures show double digit growth

According to Ad-hoc-news summarizing Amplifon's second quarter and first half 2026 results, the hearing care group delivered double digit revenue growth in H1 2026 compared with the prior year period, underpinned by higher volumes in its core retail network.

In the same H1 2026 period, Amplifon increased its adjusted EBITDA versus the first half of 2025, with the margin expanding by a few tenths of a percentage point, showing that profitability improved alongside the top line as the company continued to leverage scale and cost efficiencies.

Historical comparison from earlier fiscal years shows that Amplifon's revenue base in fiscal year 2024 was already substantially higher than in fiscal year 2023, but the H1 2026 figures now extend that trajectory by adding another double digit revenue increase on top of previous growth.

Analyst targets and strategic context

The same analyst overview cited by Ad-hoc-news indicated that the average analyst price target for Amplifon stock stood around EUR 11.48, with a high target near EUR 16.70 and a low target around EUR 11.00 as of the most recent compiled data in 2026.

This spread implies potential upside of roughly a few percent from the current level to the average target, and significantly more to the top end of the range, while the low target sits close to the prevailing price, underscoring that analysts see limited downside if the company maintains its current earnings trajectory.

Strategically, Amplifon continues to focus on expanding its global retail footprint and enhancing its service offering, with the H1 2026 revenue and adjusted EBITDA growth suggesting that this strategy is translating into tangible financial progress at least for the current reporting period.

Stock remains below recent highs

As of the most recent completed trading day on Borsa Italiana prior to September 19, 2026, Amplifon stock changed hands at around EUR 11.35, representing a small decline of about 0.78 percent on the day and leaving the share price some distance below analyst high targets near EUR 16.70, but still above the lower end of its 52 week trading range.

Amplifon stock at a glance

  • Company: Amplifon S.p.A.
  • ISIN: IT0004056880
  • Ticker: AMP
  • Trading venue: Borsa Italiana
  • Price (as of September 19, 2026, 09:56): 11.35 EUR
  • Market capitalization: 2,600,000,000 EUR (as of September 19, 2026)
  • Sector / Industry: Health Care / Medical Equipment
  • Index membership: FTSE MIB

More news and analyses on Amplifon stock

Disclaimer...

en | IT0004056880 | AMPLIFON | boerse | 70134356 | bgmi